Table 1.
Exosome | MV (MP) | AB | |
---|---|---|---|
Size | 30–200 nm | 100–1000 nm | 1000–3000 nm |
Shape | Homogeneous | Variable | Variable |
Origine | MBV fusion with the plasma membrane | Budding from the plasma membrane | Budding from the plasma membrane |
Markers | Tetraspanins (CD9, CD63, CD81) Alix, TSG101, HSP70 | Annexin V, Integrin, Selectin, CD40 ligand, metalloproteinase | Annexin V, DNA fragment Caspase 3, Histones |
Isolation | Ultracentrifugation (100,000g) | Ultracentrifugation (10,000–100,000g) | Ultracentrifugation (6000–10,000g) |
P-Act | Weak | Powerful | Powerful |
Notes: Data from Nomura.11 All vesicles preparations are heterogeneous with different protocols allowing the enrichment of one type over another.
Abbreviations: MV, microvesicle; MP, microparticle; AB, apoptotic body; MBV, multivesicular body; TSG101, tumor susceptibility gene 101; HSP70, heat shock protein 70; P-Act, procoagulant activity.